Search Within

Sujata Patil

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (70)
  2. Journal Article (55)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Biostatistics Service (127)
  2. Department of Medicine (127)
  3. Epidemiology and Biostatistics (127)
  4. Population Sciences Research Program (127)
  5. Solid Tumor Oncology Division (126)
  6. Survivorship Research (106)

More Groups

People
  1. Clifford Hudis (44)
  2. Shari Goldfarb (34)
  3. Mark Robson (32)
  4. Chau Dang (30)
  5. Larry Norton (29)
  6. Shanu Modi (25)

More People

Years
  1. 2023 (2)
  2. 2022 (6)
  3. 2021 (10)
  4. 2020 (17)
  5. 2019 (14)
  6. 2018 (10)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Cancer Research (18)
  3. Breast Cancer Research and Treatment (9)
  4. Cancer (7)
  5. The Oncologist (5)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (45)
  2. American Association for Cancer Research (22)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Wiley Blackwell (8)
  6. Oxford University Press (5)

More Publishers

Results (127)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer
    Meeting Abstract

    Wang, R.; Yu, A. F.; Steingart, R.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. T.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Dynamics of immune-mediated thyroid dysfunction in patients with advanced renal cell carcinoma receiving checkpoint inhibitor therapy
    Meeting Abstract

    Osorio, J. C.; Patil, S.; Coskey, D. T.; Carlo, M. I.; Feldman, D. R.; Hellmann, M. D.; Voss, M. H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Genomic characterization of renal medullary carcinoma and treatment outcomes
    Journal Article

    Carlo, M. I.; Chaim, J.; Patil, S.; Kemel, Y.; Schram, A. M.; Woo, K.; Coskey, D.; Nanjangud, G. J.; Voss, M. H.; Feldman, D. R.; more...
    Clinical Genitourinary Cancer (2017)

    Fulltext@MSK | Save
  • Work experiences of patients receiving palliative care at a comprehensive cancer center: Exploratory analysis
    Journal Article

    Glare, P. A.; Nikolova, T.; Alickaj, A.; Patil, S.; Blinder, V.
    Journal of Palliative Medicine (2017)

    Fulltext@MSK | Save
  • Pathologic complete response with neoadjuvant doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single center experience
    Journal Article

    Singh, J. C.; Mamtani, A.; Barrio, A.; Morrow, M.; Sugarman, S.; Jones, L. W.; Yu, A. F.; Argolo, D.; Smyth, L. M.; Modi, S.; more...
    The Oncologist (2017)

    Fulltext@MSK | Save
  • Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment
    Journal Article

    Blinder, V.; Eberle, C.; Patil, S.; Gany, F. M.; Bradley, C. J.
    Health Affairs (2017)

    Fulltext@MSK | Save
  • Correlates of work status during adjuvant chemo- or radiation therapy for breast cancer
    Meeting Abstract

    Blinder, V. S.; Eberle, C. E.; Patil, S.; Oeffinger, K. C.; Bradley, C.; Gany, F.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Activity of HP-based therapies as third and later lines for the treatment of HER2-positive metastatic breast cancer: A retrospective study from a single institution
    Meeting Abstract

    Argolo, D.; Friedman, M.; Smyth, L.; Iyengar, N.; Singh, J.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C.; Dang, C.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Iyengar, N.; Morris, P. G.; Corben, A. D.; Patil, S.; Akram, M.; Towers, R.; Sakr, R. A.; King, T. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: Overall survival and updated progression-free survival results from a phase II study
    Journal Article

    Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; more...
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save